Jennifer brings over 20 years of specialized expertise to the pharmaceutical and biotechnology sectors as a registered Canadian patent agent and strategic IP advisor. In addition to drafting and prosecution, Jennifer develops comprehensive IP strategies for companies ranging from innovative startups to established industry leaders, focusing on building robust patent portfolios that align with business objectives.
Jennifer works closely with regulatory and litigation colleagues to ensure patent strategies align with strategies recommended under the regulatory frameworks that intersect with the Canadian patent system in respect of innovative drug products, including data protection, patent listing, patent term restoration, and price controls. Her comprehensive approach addresses patent procurement, optimized market exclusivity, freedom-to-operate analysis, and competitive intelligence to support informed decision-making throughout the entire product lifecycle.
Jennifer combines technical depth with business acumen, helping organizations leverage intellectual property as a strategic asset. Whether advising on portfolio architecture, due diligence for transactions, or risk mitigation strategies, she delivers practical solutions that advance client interests in Canada's dynamic life sciences marketplace.